Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.
Variability of the 10-year cardiovascular (CV) risk predicted by the Framingham Risk Score (FRS) using lipids, FRS using body mass index (BMI), Reynolds Risk Score (RRS), QRISK2, Extended Risk Score-Rheumatoid Arthritis (ERS-RA), and algorithm developed by the American College of Cardiology and the American Heart Association in 2013 (ACC/AHA 2013) according to the European League Against Rheumatism (EULAR) 2015/2016 update of its evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis (RA) has not been evaluated in Mexican mestizo patients. CV risk was predicted using six different risk calculators in 116 patients, aged 40-75, who fulfilled the ACR/EULAR 2010 classification criteria. Results were multiplied by 1.5 according to the EULAR 2015/2016 update. Global comparison of the risk predicted by all scales was done using the Friedman test, considering a P value of ≤0.05 as statistically significant. Individual comparison between the algorithms was made using the Wilcoxon signed-rank test, and a P value of ≤0.003 was considered statistically significant. All calculators showed to be different in the Friedman test (p ≤ 0.001). Median values of predicted 10-year CV risk were 11.02% (6.18-17.55) for FRS BMI; 8.47% (4.6-13.16) for FRS lipids; 5.55% (2.5-11.85) for QRISK2; 5% (3.1-8.65) for ERS-RA; 3.6% (1.5-9.3) for ACC/AHA 2013; and 1.5% (1.5-4.5) for RRS. ERS-RA showed no difference when compared against QRISK2 (p = 0.269). CV risk calculators showed variability among them and cannot be used indistinctly in RA-patients.
Internal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico. dgalarza@medicinauanl.mx.
Dionicio A
DA
Galarza-Delgado
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Jose R
JR
Azpiri-Lopez
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Iris J
IJ
Colunga-Pedraza
Internal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Jesus A
JA
Cardenas-de la Garza
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Raymundo
R
Vera-Pineda
Internal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Griselda
G
Serna-Peña
Internal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Rosa I
RI
Arvizu-Rivera
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Adrian
A
Martinez-Moreno
Internal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Martin
M
Wah-Suarez
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Mario A
MA
Garza Elizondo
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008800:Mexico / Q000453:epidemiology; D008875:Middle Aged; D018570:Risk Assessment / Q000379:methods
Cardiovascular diseases; Rheumatoid arthritis; Risk assessment